VTGN Competitors & Alternatives
Compare VistaGen Therapeutics Inc with similar stocks in the same industry
Biotechnology
VTGN
Main Stock$0.25
Tradestie Score
52
Market Cap
$108.92M
Revenue Growth
0.3%
Analyst Upside
+301.8%
Top Competitors
237 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
STTK
Shattuck Labs, Inc. Common Stock
|
$7.05
|
$114.01M | - | 55 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$24.78
|
$110.20M | - | 58 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.69
|
$97.42M | - | 55 | Compare |
|
STRO
Sutro Biopharma, Inc.
|
$30.43
|
$76.55M | - | 58 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.28
|
$71.69M | - | 52 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$10.34
|
$67.94M | - | 56 | Compare |
|
VTVT
vTv Therapeutics Inc. Class A Common Stock
|
$35.40
|
$62.81M | - | 59 | Compare |
|
OTLK
Outlook Therapeutics, Inc. Common Stock
|
$1.45
|
$46.20M | - | 56 | Compare |
|
TENX
Tenax Therapeutics, Inc.
|
$15.46
|
$34.77M | - | 56 | Compare |
|
XBIO
Xenetic Biosciences, Inc.
|
$2.77
|
$4.78M | - | 47 | Compare |
More VTGN Analysis
Data updated: Jul 03, 2026 | Industry: Biotechnology (SIC 2834)
237 stocks in this industry